Loading viewer...
earnings
Format: PDF earnings
Moderna presents its fourth quarter and full year 2022 financial results, covering revenue from COVID-19 vaccines, pipeline progress on RSV and personalized cancer vaccines, and 2023 guidance. The presentation includes business review, R&D updates, commercial strategy, and financial outlook from CEO Stéphane Bancel and leadership team.
Hon Hai Precision Q4 2021 Financial Results
earningsearnings
22 Pages
Hon Hai Precision Industry Co., Ltd.
conference
25 Pages
earnings
20 Pages
ICE (Intercontinental Exchange)
Commonwealth Bank Australia H1 2024 Results Presentation
earningsearnings
149 Pages
Commonwealth Bank of Australia